NAT1-IN-1
NAT1-IN-1 (compound 350) is a potent N-acetyltransferase 1 (NAT1) -targeted inhibitor, with an IC50 of 44 nM. NAT1-IN-1 can be used for the research of hypermetabolic diseases such as amyotrophic lateral sclerosis, cancer cachexia, and sepsis[1].
Product Specifications
UNSPSC
12352005
Target
Histone Acetyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Field of Research
Cancer; Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/nat1-in-1.html
Purity
99.77
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=S(NC1=C(NC2=CC=C(CC(O)=O)C=C2)C(C3=CC=CC=C3C1=O)=O)(C4=CC=CC=C4)=O
Molecular Formula
C24H18N2O6S
Molecular Weight
462.47
References & Citations
[1]Chandra Choudhury, et al. Small Molecule Inhibitors of Arylamine N-Acetyltransferase 1 Attenuate Cellular Respiration.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
SH2D3C (SH2 Domain Containing 3C, CHAT, FLJ39664, NSP3, PRO34088) (MaxLight 650)